D.E. Shaw & Co
BIOL

D.E. Shaw & Co’s Biolase, Inc. BIOL Stock Holding History

D.E. Shaw & Co’s Portfolio BIOL Stock Details BIOL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-11
Closed -$139K – 3654
2017
Q2 		$139K Sell
11
-2
-15% -$29.7K ﹤0.01% 3238
2017
Q1 		$214K Sell
13
-1
-7% -$18.1K ﹤0.01% 3096
2016
Q4 		$251K Hold
14
– – ﹤0.01% 3185
2016
Q3 		$313K Hold
14
– – ﹤0.01% 3029
2016
Q2 		$205K Hold
14
– – ﹤0.01% 3180
2016
Q1 		$230K Hold
14
– – ﹤0.01% 3137
2015
Q4 		$144K Sell
14
-1
-7% -$10.9K ﹤0.01% 3628
2015
Q3 		$164K Hold
15
– – ﹤0.01% 3546
2015
Q2 		$315K Buy
15
+1
+7% +$24.4K ﹤0.01% 3391
2015
Q1 		$343K Buy
14
+6
+75% +$170K ﹤0.01% 3243
2014
Q4 		$273K Buy
8
+5
+167% +$156K ﹤0.01% 3690
2014
Q3 		$100K Buy
+3
New +$84.8K ﹤0.01% 3983

Other funds holding BIOL

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TMC
Trellus Management Company Delray Beach, Florida $72.8M AUM 4.5% 1-Year Est. Return
TA
Teton Advisors Rye, New York $142M AUM 42.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

D.E. Shaw & Co's BIOL Position: Q3 2017 in Review

D.E. Shaw & Co sold out of Biolase, Inc. (BIOL) in Q3 2017, closing a stake of 11 shares — an estimated $139K sold.

D.E. Shaw & Co first reported a position in BIOL in Q3 2014 and held it in 12 quarters. The position peaked at $343K in Q1 2015. 28 funds tracked by Wall St. Rank hold BIOL as of Q3 2017.

  • D.E. Shaw & Co reported no remaining Biolase, Inc. position as of Q3 2017 after selling out during the quarter.
  • D.E. Shaw & Co sold 11 Biolase, Inc. shares in Q3 2017, an estimated $139K.
  • D.E. Shaw & Co first reported a position in Biolase, Inc. in Q3 2014 and held it in 12 quarters.
  • D.E. Shaw & Co's Biolase, Inc. position peaked at $343K in Q1 2015.
  • 28 funds tracked by Wall St. Rank held Biolase, Inc. as of Q3 2017.

Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.